Clearstead Advisors’s CONMED CNMD Stock Holding History

Clearstead Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.02K	Sell	22 -9	-29%	-$412	﹤0.01%	2650
2026 Q2	$1.02K	Buy	+31	New	+$1.12K	﹤0.01%	2680
2025 Q3	–	Sell	-2,500	Closed	-$130K	–	3125
2025 Q2	$130K	Hold	2,500	–	–	﹤0.01%	989
2025 Q1	$151K	Sell	2,500 -71	-3%	-$4.58K	﹤0.01%	893
2024 Q4	$176K	Sell	2,571 -20	-0.8%	-$1.39K	﹤0.01%	891
2024 Q3	$186K	Hold	2,591	–	–	﹤0.01%	877
2024 Q2	$180K	Buy	2,591 +2,543	+5,298%	+$186K	﹤0.01%	846
2024 Q1	$3.5K	Hold	48	–	–	﹤0.01%	1230
2023 Q4	$5.26K	Buy	48 +22	+85%	+$2.28K	﹤0.01%	1159
2023 Q3	$2.62K	Buy	+26	New	+$2.99K	﹤0.01%	1193

Other funds holding CNMD

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $6.36B AUM 0.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Tributary Capital Management Omaha, Nebraska $1.09B AUM 35.37% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $45.4B AUM 34.02% 1-Year Est. Return

Clearstead Advisors's CNMD Position: Q3 2026 in Review

Clearstead Advisors reduced its CONMED (CNMD) stake by 29% in Q3 2026, selling an estimated $412 and leaving 22 shares worth $1.02K. The position accounts for ﹤0.01% of the portfolio, ranked #2650.

Clearstead Advisors first reported a position in CNMD in Q3 2023 and has held it in 10 quarters since. The position peaked at $186K in Q3 2024. 143 funds tracked by Wall St. Rank hold CNMD as of Q3 2026.

Clearstead Advisors held 22 shares of CONMED worth $1.02K as of Q3 2026.
Clearstead Advisors sold 9 CONMED shares in Q3 2026, an estimated $412.
CONMED made up ﹤0.01% of Clearstead Advisors's portfolio in Q3 2026, its #2650 holding.
Clearstead Advisors first reported a position in CONMED in Q3 2023 and has held it in 10 quarters since.
Clearstead Advisors's CONMED position peaked at $186K in Q3 2024.
143 funds tracked by Wall St. Rank held CONMED as of Q3 2026.

Based on Clearstead Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.